115 related articles for article (PubMed ID: 19781605)
1. Determination of poly(epsilon-caprolactone) solubility parameters: application to solvent substitution in a microencapsulation process.
Bordes C; Fréville V; Ruffin E; Marote P; Gauvrit JY; Briançon S; Lantéri P
Int J Pharm; 2010 Jan; 383(1-2):236-43. PubMed ID: 19781605
[TBL] [Abstract][Full Text] [Related]
2. The microencapsulation of protein using a novel ternary blend based on poly(epsilon-caprolactone).
Huatan H; Collett JH; Attwood D
J Microencapsul; 1995; 12(5):557-67. PubMed ID: 8544099
[TBL] [Abstract][Full Text] [Related]
3. Poly (epsilon-caprolactone) microparticles containing Levobunolol HCl prepared by a multiple emulsion (W/O/W) solvent evaporation technique: effects of some formulation parameters on microparticle characteristics.
Karataş A; Sonakin O; Kiliçarslan M; Baykara T
J Microencapsul; 2009 Feb; 26(1):63-74. PubMed ID: 18608798
[TBL] [Abstract][Full Text] [Related]
4. Microencapsulation of superoxide dismutase into poly(epsilon-caprolactone) microparticles by reverse micelle solvent evaporation.
Youan BB
Drug Deliv; 2003; 10(4):283-8. PubMed ID: 14612345
[TBL] [Abstract][Full Text] [Related]
5. Application of Hansen solubility parameters for understanding and prediction of drug distribution in microspheres.
Vay K; Scheler S; Friess W
Int J Pharm; 2011 Sep; 416(1):202-9. PubMed ID: 21745557
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable, somatostatin acetate containing microspheres prepared by various aqueous and non-aqueous solvent evaporation methods.
Herrmann J; Bodmeier R
Eur J Pharm Biopharm; 1998 Jan; 45(1):75-82. PubMed ID: 9689538
[TBL] [Abstract][Full Text] [Related]
7. Ammonolysis-based microencapsulation technique using isopropyl formate as dispersed solvent.
Im HY; Sah H
Int J Pharm; 2009 Dec; 382(1-2):130-8. PubMed ID: 19715744
[TBL] [Abstract][Full Text] [Related]
8. Effects of block length on the enzymatic degradation and erosion of oxazoline linked poly-epsilon-caprolactone.
Pulkkinen M; Malin M; Tarvainen T; Saarimäki T; Seppälä J; Järvinen K
Eur J Pharm Sci; 2007 Jun; 31(2):119-28. PubMed ID: 17433634
[TBL] [Abstract][Full Text] [Related]
9. Encapsulation of water-soluble drugs by a modified solvent evaporation method. I. Effect of process and formulation variables on drug entrapment.
Alex R; Bodmeier R
J Microencapsul; 1990; 7(3):347-55. PubMed ID: 2384837
[TBL] [Abstract][Full Text] [Related]
10. Lactic acid bacteria-enclosing poly(epsilon-caprolactone) microcapsules as soil bioamendment.
Takei T; Yoshida M; Hatate Y; Shiomori K; Kiyoyama S
J Biosci Bioeng; 2008 Sep; 106(3):268-72. PubMed ID: 18930004
[TBL] [Abstract][Full Text] [Related]
11. Improvement of a bovine serum albumin microencapsulation process by screening design.
Al Haushey L; Bolzinger MA; Bordes C; Gauvrit JY; Briançon S
Int J Pharm; 2007 Nov; 344(1-2):16-25. PubMed ID: 17651928
[TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization and in vitro drug release of poly-epsilon-caprolactone and hydroxypropyl methylcellulose phthalate ketoprofen loaded microspheres.
Guzman M; Molpeceres J; Garcia F; Aberturas MR
J Microencapsul; 1996; 13(1):25-39. PubMed ID: 8903783
[TBL] [Abstract][Full Text] [Related]
13. Polymeric matrix for drug delivery: honokiol-loaded PCL-PEG-PCL nanoparticles in PEG-PCL-PEG thermosensitive hydrogel.
Gou M; Gong C; Zhang J; Wang X; Wang X; Gu Y; Guo G; Chen L; Luo F; Zhao X; Wei Y; Qian Z
J Biomed Mater Res A; 2010 Apr; 93(1):219-26. PubMed ID: 19557789
[TBL] [Abstract][Full Text] [Related]
14. Microencapsulation of antimicrobial ceftiofur drugs.
Bodmeier R; Chen H; Davidson RG; Hardee GE
Pharm Dev Technol; 1997 Nov; 2(4):323-34. PubMed ID: 9552461
[TBL] [Abstract][Full Text] [Related]
15. Encapsulation of hydrophobic drugs in polymeric micelles through co-solvent evaporation: the effect of solvent composition on micellar properties and drug loading.
Aliabadi HM; Elhasi S; Mahmud A; Gulamhusein R; Mahdipoor P; Lavasanifar A
Int J Pharm; 2007 Feb; 329(1-2):158-65. PubMed ID: 17008034
[TBL] [Abstract][Full Text] [Related]
16. Lipophilic prodrugs of Hsp90 inhibitor geldanamycin for nanoencapsulation in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles.
Forrest ML; Zhao A; Won CY; Malick AW; Kwon GS
J Control Release; 2006 Nov; 116(2):139-49. PubMed ID: 16926059
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinase inhibitor loaded PCL microspheres prepared by S/O/W technique using ethanol as pretreatment agent.
Zhang Y; Zhang Y; Guo S; Huang W
Int J Pharm; 2009 Mar; 369(1-2):19-23. PubMed ID: 19041382
[TBL] [Abstract][Full Text] [Related]
18. Micelles of methoxy poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A.
Aliabadi HM; Mahmud A; Sharifabadi AD; Lavasanifar A
J Control Release; 2005 May; 104(2):301-11. PubMed ID: 15907581
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of felodipine-located poly(epsilon-caprolactone) microspheres.
Kim BK; Hwang SJ; Park JB; Park HJ
J Microencapsul; 2005 Mar; 22(2):193-203. PubMed ID: 16019904
[TBL] [Abstract][Full Text] [Related]
20. Comparison of process parameters for microencapsulation of plasmid DNA in poly(D,L-lactic-co-glycolic) acid microspheres.
Hsu YY; Hao T; Hedley ML
J Drug Target; 1999 Dec; 7(4):313-23. PubMed ID: 10682910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
